Overview
Status
Active
Registry date
2019-10-16
Share capital
5,000.00 PLN
Activity description
Denovoned is a company that specializes in accelerating drug discovery through its expertise in computational medicinal chemistry.
Registered address
Plac Bankowy 2, 00-095 Warszawa, Poland
Website
Electronic delivery address
AE:PL-85081-61333-WVJAR-13
Financials
Revenue history
From the notes
| Current income tax (CIT due) | $0 |
Filing timeliness
1 of 6 financial statements was filed late (for 2021, 89 days late).
- 202512/07/2026
- 202430/06/2025
- 202313/07/2024
- 202215/07/2023
- 202112/10/2022
- 202015/07/2021
Filed on timeDelayFiling deadline
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Website technology
- Analytics and marketing
- Google Analytics
Authorized Representatives
Dariusz Michał Ekonomiukage 46 – President of the Management Board
Manner of representation
Each member of the management board is authorized to make declarations on behalf of the company independently.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Dariusz Michał Ekonomiukage 46 | 98 | $1,323.61 | 98% |
Others | 2 | $27.01 | 2% |
Beneficial owners
| Person | Rights |
|---|---|
Debt
No entries in the National Debtors Register (KRZ).
Public aid
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Jun 20, 2020 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | $1,282$1,282 | Prezydent Miasta Stołecznego Warszawy |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| GenomedS.A. | $7,373,750.46 | genomed.pl | ||
| Read-GeneS.A. | $2,163,474.84 | read-gene.com | ||
| Orphinic ScientificS.A. | $518,429.97 | orphinic.com | ||
| Proper Medical Writingsp. z o.o. | $514,848.41 | propermedicalwriting.com | ||
| Medicofarma BiotechS.A. | $314,882.33 | medicofarmabiotech.pl | ||
| Zawamedsp. z o.o. | $43,909.06 | zawamed.pl | ||
| Stenocoatsp. z o.o. | $36,665.21 | stenocoat.com | ||
| NanovelosS.A. | $24,842.03 | nanovelos.com | ||
| Spektrinosp. z o.o. | $21,528.32 | spektrino.com | ||
| Detoxedsp. z o.o. | $11,972.37 | detoxed.pl |
FAQ
The main business activity of Denovoned focuses on research and experimental development on biotechnology.
The company was registered in the Polish National Court Register (KRS) on October 16, 2019.
The headquarters is located at: Plac Bankowy 2, 00-095 Warszawa.
The share capital of the company is PLN 5,000 (approx. $1,351).
The latest available financial statement covers the period from January 1, 2024 to December 31, 2024.
Last updated: 2026-07-14